Santarus, Inc. (Nasdaq: SNTS) announced that the U.S. Food and Drug Administration (FDA) has approved UCERIS (budesonide) extended release tablets ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE